Suchergebnisse - "Nadal, Ernest"

PubPharm (164)

1

Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC) : 2023 expert consensus of the Spanish Lung Cancer Group GECP

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2024

von Ospina, A. | Bolufer Nadal, S. | Campo-Cañaveral de la Cruz, J. | +26

2

RET Fusion Testing in Patients With NSCLC : The RETING Study

enthalten in: JTO clinical and research reports | 2024

von Conde, E. | Hernandez, S. | Rodriguez Carrillo, J. | +37

3

A plain language summary of the PHAROS study : the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer

enthalten in: Future oncology (London, England) | 2024

von Riely, G. | Smit, E. | Ahn, M. | +22

4

Transcriptional analysis of landmark molecular pathways in lung adenocarcinoma results in a clinically relevant classification with potential therapeutic implications

enthalten in: Molecular oncology | 2024

von Hijazo-Pechero, S. | Alay, A. | Cordero, D. | +7

5

Difficulties on the access to innovative targeted therapies for lung cancer in Spain

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2024

von Calvo, V. | Camps, C. | Carcereny, E. | +13

6

Reply to E.J. Lehrer et al and J.B. De Vis et al

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Nadal, E. | Vilariño, N. | Simó, M. | +2

7

RELAY, Erlotinib Plus Ramucirumab in Untreated, EGFR-Mutated, Metastatic NSCLC : Outcomes by EGFR Exon 19 Deletion Variants

enthalten in: JTO clinical and research reports | 2024

von Nishino, K. | Shih, J. | Nakagawa, K. | +6

8

Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1-High Advanced NSCLC : A Randomized, Open-Label, Phase 3 Trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Cho, B. | Lee, J. | Wu, Y. | +22

CommentIn: J Thorac Oncol. 2023 Dec;18(12):1629-1631. - PMID 37993216

9

Brief report : High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer

enthalten in: Thrombosis research | 2023

von Aparicio, I. | Iranzo, P. | Reyes, R. | +27

10

A Transcriptomic Approach Outperforms Mutational Analysis to Identify KEAP1/NFE2L2 Pathway Activation in Patients With NSCLC

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Hijazo-Pechero, S. | Muñoz-Pinedo, C. | Nadal, E.

CommentOn: J Thorac Oncol. 2023 Nov;18(11):1550-1567. - PMID 37473958

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]